Penserra Capital Management LLC Kaleido Biosciences, Inc. Transaction History

Penserra Capital Management LLC

  • $7.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$2.39 - $6.02 $2,318 - $5,839
-970 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$5.82 - $8.72 $174 - $261
30 Added 3.19%
970 $7,000
Q1 2021

May 13, 2021
BUY
$7.2 - $16.82 $648 - $1,513
90 Added 10.59%
940 $7,000
Q4 2020

Feb 12, 2021
BUY
$5.77 - $11.33 $4,904 - $9,630
850 New
850 $7,000

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email